Evidence map›Paper›PMID 38572329›Full record

ReviewArchivos peruanos de cardiologia y cirugia cardiovascular

[Arrhythmias and Sudden Death Risk in Hypertrophic Cardiomyopathy].

Jorge Salinas-Arce, Ana Cecilia Gonzales-Luna, Mario Cabrera-Saldaña, Pablo Mendoza-Novoa, Raúl Alca-Clares, Paula Solorzano-Altamirano, Freddy Del Carpio-Muñoz

Open access · diamondAbstract readEnglish AbstractReview
In one paragraph

Review in Archivos peruanos de cardiologia y cirugia cardiovascular. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jorge Salinas-ArceUnidad de Arritmias. Clínica Delgado. Lima, Perú. Unidad de Arritmias Clínica Delgado Lima Perú.
Ana Cecilia Gonzales-LunaUnidad de Arritmias. Clínica Delgado. Lima, Perú. Unidad de Arritmias Clínica Delgado Lima Perú.
Mario Cabrera-SaldañaUnidad de Arritmias. Clínica Delgado. Lima, Perú. Unidad de Arritmias Clínica Delgado Lima Perú.
Pablo Mendoza-NovoaUnidad de Arritmias. Clínica Delgado. Lima, Perú. Unidad de Arritmias Clínica Delgado Lima Perú.
Raúl Alca-ClaresMédico residente de Cardiología. Hospital Nacional Cayetano Heredia. Lima, Perú. Hospital Nacional Cayetano Heredia Lima Perú.
Paula Solorzano-AltamiranoUnidad de Arritmias. Clínica San Felipe. Lima, Perú. Unidad de Arritmias Clínica San Felipe Lima Perú.
Freddy Del Carpio-MuñozProfesor asistente. Mayo Clinic School of Medicine, Rochester, Minessota, EEUU. Mayo Clinic College of Medicine Mayo Clinic School of Medicine, Rochester Minessota USA.
Centro Peruano de Estudios Sociales · PEInstituto Nacional de Salud del Niño · PEUniversidad Peruana Cayetano Heredia · PE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The risk of sudden death in hypertrophic cardiomyopathy is related to the presence of ventricular arrhythmias in most cases. Finding the best schemes to assess the probability of arrhythmic complications will remain a challenge for modern Cardiology. Meanwhile, the multifactorial approach is the best strategy to avoid the unnecessary implantation of devices such as the implantable cardioverter defibrillator. Although the electrocardiogram remains an excellent diagnostic tool, even before echocardiographic expression, it does not have a clear role as a risk factor. However, the identification of associated arrhythmias such as preexcitation or long QT and variants of presentation as apical hypertrophic cardiomyopathy, allows identifying patients with high probability of sudden death. During the last few years, cardiac resonance and quantification of intramyocardial fibrosis (the basic mechanism of ventricular arrhythmias) have gained an important role in the evaluation of these patients.In particular, pediatric patients must have an individualized approach due to the poor prognosis at early ages and the uncertain role of different tools for risk assessment and treatment.

Indexed as

arrhythmiashypertrophic cardiomyopathysudden death

Identifiers

PMID38572329
PMCPMC10986354
OpenAlexW3080444309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.